OXFORD ASSET MANAGEMENT LLP - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 47 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 2.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q4 2019$1,130,000
+826.2%
495,807
+243.8%
0.03%
+933.3%
Q3 2019$122,000
-81.7%
144,232
-29.9%
0.00%
-82.4%
Q4 2018$667,000
+260.5%
205,734
+771.5%
0.02%
+240.0%
Q1 2017$185,00023,6060.01%
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q1 2020.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders